DocumentUNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Report on Form 6-K dated June 29, 2024
Commission File Number: 1-13546
STMicroelectronics N.V.
(Name of Registrant)
WTC Schiphol Airport
Schiphol Boulevard 265
1118 BH Schiphol Airport
The Netherlands
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F T Form 40-F £
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes £ No T
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No T
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes ☐ No T
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- __________
Enclosure: STMicroelectronics N.V.’s Second Quarter and Six Months ended June 29, 2024:
•Operating and Financial Review and Prospects;
•Unaudited Interim Consolidated Statements of Income, Statements of Comprehensive Income, Balance Sheets, Statements of Cash Flows, and Statements of Equity and related Notes for the three and six months ended June 29, 2024; and
•Certifications pursuant to Sections 302 (Exhibits 12.1 and 12.2) and 906 (Exhibit 13.1) of the Sarbanes-Oxley Act of 2002, submitted to the Commission on a voluntary basis.
OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Overview
The following discussion should be read in conjunction with our Unaudited Interim Consolidated Statements of Income, Statements of Comprehensive Income, Balance Sheets, Statements of Cash Flows and Statements of Equity as of June 29, 2024 and for the three and six months ended June 29, 2024 and Notes thereto included elsewhere in this Form 6-K, and our annual report on Form 20-F as of December 31, 2023 and for the year ended December 31, 2023 as filed with the U.S. Securities and Exchange Commission (the “Commission” or the “SEC”) on February 22, 2024 (the “Form 20-F”). The following discussion contains statements of future expectations and other forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or Section 21E of the Securities Exchange Act of 1934, each as amended, particularly in the sections “Business Overview” and “Liquidity and Capital Resources—Financial Outlook: Capital Investment”. Our actual results may differ significantly from those projected in the forward-looking statements. For a discussion of factors that might cause future actual results to differ materially from our recent results or those projected in the forward-looking statements in addition to the factors set forth below, see “Cautionary Note Regarding Forward-Looking Statements” and “Item 3. Key Information—Risk Factors” included in the Form 20-F. We assume no obligation to update the forward-looking statements or such risk factors.
Our Management’s Discussion and Analysis of Financial Position and Results of Operations (“MD&A”) is provided in addition to the accompanying Unaudited Interim Consolidated Financial Statements (“Consolidated Financial Statements”) and Notes to assist readers in understanding our results of operations, financial condition and cash flows. Our MD&A is organized as follows:
•Critical Accounting Policies using Significant Estimates.
•Business Overview, a discussion of our business and overall analysis of financial and other relevant highlights for the three and six months ended June 29, 2024, designed to provide context for the other sections of the MD&A, including our expectations for selected financial items for the third quarter of 2024.
•Other Developments.
•Results of Operations, containing a year-over-year and sequential analysis of our financial results for the three and six months ended June 29, 2024, as well as segment information.
•Legal Proceedings.
•Discussion on the impact of changes in exchange rates, interest rates and equity prices on our activity and financial results.
•Liquidity and Capital Resources, presenting an analysis of changes in our balance sheets and cash flows, and discussing our financial condition and potential sources of liquidity.
•Impact of Recently Issued U.S. Accounting Standards.
•Backlog and Customers, discussing the level of backlog and sales to our key customers.
•Disclosure Controls and Procedures.
•Other reviews.
•Cautionary Note Regarding Forward-Looking Statements.
At STMicroelectronics N.V. (“ST” or the “Company”), we are over 50,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. As an integrated device manufacturer, we work with more than 200,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of cloud-connected autonomous things. We are committed to achieving our goal to become carbon neutral on scope 1 and 2 and partially scope 3 by 2027.
Critical Accounting Policies Using Significant Estimates
There were no material changes in the first six months of 2024 to the information provided under the heading “Critical Accounting Policies Using Significant Estimates” included in our Form 20-F for the year ended December 31, 2023, as described in Note 5, Recent Accounting Pronouncements, of the Consolidated Financial Statements for the three and six months ended June 29, 2024.
Fiscal Year
Under Article 35 of our Articles of Association, our fiscal year extends from January 1 to December 31. The first quarter of 2024 ended on March 30 and the second quarter ended on June 29. The third quarter will end on September 28 and the fourth quarter will end on December 31, 2024. Based on our fiscal calendar, the distribution of our revenues and expenses by quarter may be unbalanced due to a different number of days in the various quarters of the fiscal year and can also differ from equivalent prior-years’ periods, as illustrated in the below table for the years 2024 and 2023.
| | | | | | | | | | | | | | |
| Q1 | Q2 | Q3 | Q4 |
| Days |
2023 | 91 | 91 | 91 | 92 |
2024 | 90 | 91 | 91 | 94 |
Business Overview
Our results of operations for each period were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | % Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions, except per share amounts) | | | | |
Net revenues | | $ | 3,232 | | | $ | 3,465 | | | $ | 4,326 | | | (6.7) | % | | (25.3) | % |
Gross profit | | 1,296 | | | 1,444 | | | 2,119 | | | (10.2) | | | (38.9) | |
Gross margin (as percentage of net revenues) | | 40.1 | % | | 41.7 | % | | 49.0 | % | | -160 bps | | -890 bps |
Operating income | | 375 | | | 551 | | | 1,146 | | | (32.0) | | | (67.3) | |
Operating margin (as percentage of net revenues) | | 11.6 | % | | 15.9 | % | | 26.5 | % | | -430 bps | | -1,490 bps |
Net income attributable to parent company | | 353 | | | 513 | | | 1,001 | | | (31.2) | | | (64.8) | |
Diluted earnings per share | | $ | 0.38 | | | $ | 0.54 | | | $ | 1.06 | | | (29.6) | % | | (64.2) | % |
Our total available market is defined as “TAM”, while our serviceable available market is defined as “SAM” and represents the market for products sold by us (i.e., TAM excluding major devices such as microprocessors, GPU/AI accelerators, DRAM and flash-memories, optoelectronics devices other than optical sensors, video processing and wireless application specific market products, such as baseband and application processors).
Based on industry data published by World Semiconductor Trade Statistics, on a sequential basis, semiconductor industry revenues in the second quarter of 2024 increased by approximately 7% for our TAM and decreased by approximately 1% for our SAM to reach approximately $150 billion and $59 billion, respectively. On a year-over-year basis, our TAM increased by approximately 18% and our SAM decreased by approximately 9%.
The new organization we announced on January 10, 2024 resulted in a change in our segment reporting from three to four reportable segments. Prior-year comparative information has been adjusted accordingly.
Our second quarter 2024 net revenues amounted to $3,232 million, decreasing 6.7% sequentially, about 90 basis points above the mid-point of our business outlook range, driven by higher revenues in Personal Electronics, partially offset by lower than expected revenues in Automotive. On a sequential basis, Analog products, MEMS and Sensors (“AM&S”) segment revenues decreased 4.3%, Power and discrete products (“P&D”) segment
revenues decreased 8.8%, Microcontrollers (“MCU”) segment revenues decreased 15.7% and Digital ICs and RF Products (“D&RF”) segment revenues increased 8.6%.
On a year-over-year basis, second quarter net revenues decreased 25.3% with lower sales in all reportable segments. AM&S revenues decreased 10.0%, P&D revenues decreased 24.4%, MCU revenues decreased by 46.0% and D&RF revenues decreased 7.6%.
Our revenue performance was below the SAM on a sequential and a year-over-year basis.
Our effective average exchange rate for the second quarter of 2024 was $1.08 for €1.00, compared to $1.09 in the first quarter of 2024 and $1.08 in the second quarter of 2023. For a more detailed discussion of our hedging arrangements and the impact of fluctuations in exchange rates, see “Impact of Changes in Exchange Rates”.
Our second quarter of 2024 gross profit was $1,296 million and gross margin was 40.1%, in line with the mid-point of the outlook range. On a sequential and on a year-over-year basis, gross margin decreased 160 basis points and 890 basis points respectively, mainly due to the combination of product mix and sales price and higher unused capacity charges.
Our aggregated selling, general & administrative (“SG&A”) and research & development (“R&D”) expenses amounted to $954 million, compared to $953 million and $969 million in the prior and year-ago quarters, respectively. On a sequential basis, operating expenses remained substantially flat. On a year-over-year basis, operating expenses decreased by $15 million, mainly due to the negative non-recurring non-cash items that occurred in the year-ago quarter.
Other income and expenses, net, amounted to $33 million income, decreasing by $27 million sequentially due to lower publing funding and increasing by $37 million on a year-over-year basis due to higher public funding.
In the second quarter of 2024, our operating income was $375 million, equivalent to 11.6% of net revenues, compared to $551 million (15.9% of net revenues) in the previous quarter, and to $1,146 million (26.5% of net revenues) in the year-ago quarter. On a sequential and year-over-year basis, operating income was mainly impacted by decreased gross margin profitability.
In the second quarter of 2024, our net cash from operating activities amounted to $702 million. Our net cash used in investing activities was at $628 million with Net Capex (non-U.S. GAAP measure) at $528 million compared to $967 million and $1,072 million during prior and year-ago quarters, respectively.
Our free cash flow, a non-U.S. GAAP measure, amounted to positive $159 million in the second quarter of 2024 compared to positive $209 million in the second quarter of 2023. Refer to “Liquidity and Capital Resources” for the reconciliation of the free cash flow, a non-U.S. GAAP measure, to our consolidated Statements of Cash Flows.
Looking at the third quarter, we expect a revenue increase of approximately 0.6% sequentially, plus or minus 350 basis points. Gross margin is expected to be approximately 38.0%, plus or minus 200 basis points.
This outlook is based on an assumed effective currency exchange rate of approximately $1.07 = €1.00 for the third quarter of 2024 and includes the impact of existing hedging contracts. The third quarter will close on September 28, 2024.
These are forward-looking statements that are subject to known and unknown risks and uncertainties that could cause actual results to differ materially; in particular, refer to those known risks and uncertainties described in “Cautionary Note Regarding Forward-Looking Statements” and Item 3. “Key Information — Risk Factors” in our Form 20-F as may be updated from time to time in our SEC filings.
Other Developments
On June 21, we announced the completion of the three-year share buy-back programs of $1,040 million initiated in 2021 and the launch of a new share buy-back plan comprising of two programs, totaling up to $1,100 million to be executed within a 3-year period. We intend to carry out the buy-back programs and hold the shares bought back as treasury stock for the purpose of meeting our obligations in relation to our employee stock award plans and to support the potential settlement of our outstanding convertible bonds.
On May 31, we announced our plan to build a new fully integrated silicon carbide facility in Catania, Italy for the mass production of 200mm silicon carbide wafers. The new facility is targeted to start production in 2026 and to ramp to full capacity by 2033, with up to 15,000 wafers per week at full build-out. The total investment is expected to be around five billion euros, with a support of around two billion euros provided by the State of Italy within the framework of the EU Chips Act. Sustainable practices are integral to the design, development, and operation of the Silicon Carbide Campus to ensure the responsible consumption of resources including water and power.
On May 22, we held our Annual General Meeting of Shareholders (AGM) in Schiphol, the Netherlands. The proposed resolutions, all approved by the Shareholders, were:
•The adoption of the Company's Statutory Annual Accounts for the year ended December 31, 2023, prepared in accordance with International Financial Reporting Standards (IFRS) and filed with the Netherlands Authority for the Financial Markets (AFM) on March 21, 2024;
•The distribution of a cash dividend of $0.36 per outstanding share of the Company’s common stock to be distributed in quarterly installments of $0.09 in each of the second, third and fourth quarters of 2024 and first quarter of 2025 to shareholders of record in the month of each quarterly payment;
•The amendment to the Company's Articles of Association;
•The adoption of the Remuneration Policy for the Supervisory Board;
•The adoption of the Remuneration Policy for the Managing Board;
•The reappointment of Mr. Jean-Marc Chery as member and Chairman of the Managing Board for a three-year term to expire at the end of the 2027 AGM;
•The approval of the stock-based portion of the compensation of the President and CEO;
•The appointment of Mr. Lorenzo Grandi as member of the Managing Board for a three-year term to expire at the end of the 2027 AGM;
•The approval of the stock-based portion of the compensation of the Chief Financial Officer;
•The approval of a new 3-year Unvested Stock Award Plan for Management and Key Employees;
•The reappointment of EY as external auditor for the 2024 and 2025 financial years;
•The reappointment of Mr. Nicolas Dufourcq, as member of the Supervisory Board, for a three-year term to expire at the end of the 2027 AGM;
•The reappointment of Ms. Janet Davidson, as member of the Supervisory Board, for a one-year term to expire at the end of the 2025 AGM;
•The appointment of Mr. Pascal Daloz, as member of the Supervisory Board, for a three-year term expiring at the 2027 AGM, in replacement of Mr. Yann Delabrière whose mandate will expire at the end of the 2024 AGM;
•The authorization to the Managing Board, until the conclusion of the 2025 AGM, to repurchase shares, subject to the approval of the Supervisory Board;
•The delegation to the Supervisory Board of the authority to issue new common shares, to grant rights to subscribe for such shares, and to limit and/or exclude existing shareholders’ pre-emptive rights on common shares, until the end of the 2025 AGM;
•The discharge of the member of the Managing Board; and
•The discharge of the members of the Supervisory Board.
Results of Operations
Segment Information
We design, develop, manufacture and market a broad range of products, including discrete and standard commodity components, application-specific integrated circuits (“ASICs”), full-custom devices and semi-custom devices and application-specific standard products (“ASSPs”) for analog, digital and mixed-signal applications. In addition, we further participate in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards.
On January 10, 2024, we announced a new organization to deliver enhanced product development innovation and efficiency, time-to-market as well as customer focus by end market. This new organization resulted in a change in segment reporting effective from January 1, 2024. Prior-year comparative information has been adjusted accordingly.
Our reportable segments are as follows:
•Analog products, MEMS and Sensors (“AM&S”), comprised of ST analog products, MEMS sensors and actuators, and optical sensing solutions.
•Power and discrete products (“P&D”), comprised of discrete and power transistor products.
•Microcontrollers (“MCU”), comprised of general-purpose and automotive microcontrollers, microprocessors and connected security products (incl. EEPROM).
•Digital ICs and RF Products (“D&RF”), comprised of automotive ADAS, infotainment, RF and communications products.
Net revenues of “Others” include revenues from sales assembly services and other revenues. For the computation of the segments’ internal financial measurements, we use certain internal rules of allocation for the costs not directly chargeable to the segments, including cost of sales, SG&A expenses and a part of R&D expenses. In compliance with our internal policies, certain costs are not allocated to the segments, but reported in “Others”. Those comprise unused capacity charges, including incidents leading to power outage, impairment and restructuring charges, management reorganization expenses, start-up and phase-out costs, and other unallocated income (expenses) such as: strategic or special R&D programs, certain corporate-level operating expenses, patent claims and litigations, and other costs that are not allocated to reportable segments, as well as operating earnings of other products. Finally, public grants are allocated to our segments proportionally to the incurred expenses on the sponsored projects.
Second Quarter 2024 vs. First Quarter 2024 and Second Quarter 2023
The following table sets forth certain financial data from our Unaudited Interim Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | $ million | | % of net revenues | | $ million | | % of net revenues | | $ million | | % of net revenues |
Net sales | | $ | 3,227 | | | 99.8 | % | | $ | 3,444 | | | 99.4 | % | | $ | 4,320 | | | 99.9 | % |
Other revenues | | 5 | | | 0.2 | | | 21 | | | 0.6 | | | 6 | | | 0.1 | |
Net revenues | | 3,232 | | | 100.0 | | | 3,465 | | | 100.0 | | | 4,326 | | | 100.0 | |
Cost of sales | | (1,936) | | | (59.9) | | | (2,021) | | | (58.3) | | | (2,207) | | | (51.0) | |
Gross profit | | 1,296 | | | 40.1 | | | 1,444 | | | 41.7 | | | 2,119 | | | 49.0 | |
Selling, general and administrative expenses | | (419) | | | (13.0) | | | (425) | | | (12.3) | | | (414) | | | (9.6) | |
Research and development expenses | | (535) | | | (16.5) | | | (528) | | | (15.2) | | | (555) | | | (12.8) | |
Other income and expenses, net | | 33 | | | 1.0 | | | 60 | | | 1.7 | | | (4) | | | (0.1) | |
| | | | | | | | | | | | |
Operating income | | 375 | | | 11.6 | | | 551 | | | 15.9 | | | 1,146 | | | 26.5 | |
Interest income, net | | 51 | | | 1.6 | | | 59 | | | 1.7 | | | 33 | | | 0.8 | |
Other components of pension benefit costs | | (4) | | | (0.1) | | | (4) | | | (0.1) | | | (5) | | | (0.1) | |
| | | | | | | | | | | | |
Loss on financial instruments, net | | (1) | | | — | | | — | | | — | | | — | | | — | |
Income before income taxes and noncontrolling interest | | 421 | | | 13.0 | | | 606 | | | 17.5 | | | 1,174 | | | 27.1 | |
Income tax expense | | (67) | | | (2.1) | | | (92) | | | (2.7) | | | (171) | | | (4.0) | |
Net income | | 354 | | | 11.0 | | | 514 | | | 14.8 | | | 1,003 | | | 23.2 | |
Net income attributable to noncontrolling interest | | (1) | | | — | | | (1) | | | — | | | (2) | | | — | |
Net income attributable to parent company | | $ | 353 | | | 10.9 | % | | $ | 513 | | | 14.8 | % | | $ | 1,001 | | | 23.1 | % |
Net revenues
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | % Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions) | | | | |
Net sales | | $ | 3,227 | | | $ | 3,444 | | | $ | 4,320 | | | (6.3) | % | | (25.3) | % |
Other revenues | | 5 | | | 21 | | | 6 | | | (75.5) | | | (10.3) | |
Net revenues | | 3,232 | | | 3,465 | | | 4,326 | | | (6.7) | % | | (25.3) | % |
Sequentially, our second quarter 2024 net revenues decreased 6.7%, 90 basis points better than the mid-point of our released guidance. The sequential decrease resulted from lower average selling prices of approximately 12%, driven by a less favorable product mix and lower selling prices, partially offset by higher volumes of approximately 5%.
On a year-over-year basis, net revenues decreased 25.3% mainly as a result of lower average selling prices of approximately 21%, driven by a less favorable product mix and lower selling prices, and lower volumes of approximately 4%.
Net revenues by reportable segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | % Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions) | | | | |
AM&S segment | | $ | 1,165 | | | $ | 1,217 | | | $ | 1,293 | | | (4.3) | % | | (10.0) | % |
P&D segment | | 747 | | | 820 | | | 989 | | | (8.8) | | | (24.4) | |
Analog, Power & Discrete, MEMS and Sensors Group (APMS) | | 1,912 | | | 2,037 | | | 2,282 | | | (6.1) | | | (16.2) | |
MCU segment | | 800 | | | 950 | | | 1,482 | | | (15.7) | | | (46.0) | |
D&RF segment | | 516 | | | 475 | | | 558 | | | 8.6 | | | (7.6) | |
Microcontrollers, Digital ICs and RF products Group (MDRF) | | 1,316 | | | 1,425 | | | 2,040 | | | (7.6) | | | (35.5) | |
Others | | 4 | | | 3 | | | 4 | | | 30.3 | | | 4.9 | |
Total consolidated net revenues | | $ | 3,232 | | | $ | 3,465 | | | $ | 4,326 | | | (6.7) | % | | (25.3) | % |
On a sequential basis, AM&S revenues decreased 4.3%, driven by lower average selling prices of approximately 9% mainly due to product mix, partially offset by higher volumes of approximately 5%. P&D revenues decreased 8.8%, due to lower average selling prices of approximately 20% mainly driven by product mix, partially offset by higher volumes of approximately 11%. MCU revenues decreased 15.7% due to lower average selling prices of approximately 8% driven by product mix and selling prices, and lower volumes of approximately 8%. D&RF revenues increased by 8.6%, driven by higher volumes of approximately 12%, partially offset by lower average selling prices of approximately 3% .
On a year-over-year basis, AM&S revenues decreased 10.0%, driven by lower average selling prices of approximately 10% mainly due to product mix and lower selling prices. P&D revenues decreased 24.4% compared to the year-ago quarter, driven by lower average selling prices of approximately 20% due to product mix and lower selling prices, and lower volumes of approximately 4%. MCU revenues decreased 46.0%, driven by lower average selling prices of approximately 23%, due to product mix and lower selling prices, and lower volumes of approximately 23%. D&RF revenues decreased by 7.6% mainly due to lower average selling prices linked to a less favorable product mix.
Net Revenues by Market Channel (1)
| | | | | | | | | | | | | | | | | | | | |
| | Three Months ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | | | | | |
Original Equipment Manufacturers (“OEM”) | | 73 | % | | 70 | % | | 64 | % |
Distribution | | 27 | | | 30 | | | 36 | |
Total consolidated net revenues | | 100 | % | | 100 | % | | 100 | % |
(1) OEM are the end-customers to which we provide direct marketing application engineering support, while Distribution refers to the distributors and representatives that we engage to distribute our products around the world.
By market channel, our second quarter net revenues in distribution amounted to 27% of our total consolidated net revenues, decreasing from 30% and 36% in the prior and year-ago quarter respectively.
Net Revenues by Location of Shipment (1)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | % Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions) | | |
Europe, Middle East, Africa (“EMEA”) | | $ | 840 | | | $ | 953 | | | $ | 1,244 | | | (11.9) | % | | (32.5) | % |
Americas | | 505 | | | 520 | | | 698 | | | (2.7) | | | (27.6) | |
Asia Pacific | | 1,887 | | | 1,992 | | | 2,384 | | | (5.3) | | | (20.8) | |
Total consolidated net revenues | | $ | 3,232 | | | $ | 3,465 | | | $ | 4,326 | | | (6.7) | % | | (25.3) | % |
(1)Net revenues by location of shipment are classified by location of customer invoiced or reclassified by shipment destination in line with customer demand. For example, products ordered by U.S. based companies to be invoiced to Asia Pacific affiliates are classified as Asia Pacific revenues. Furthermore, the comparison among the different periods may be affected by shifts in shipments from one location to another, as requested by our customers.
On a sequential basis, EMEA revenues decreased 11.9%, mainly due to lower sales in General-Purpose Microcontrollers, Auto Processing & RF and Analog. Americas revenues decreased 2.7% due to lower sales in Power & Discrete and General-Purpose Microcontrollers. Asia Pacific revenues decreased 5.3% due to lower revenues in General-Purpose Microcontrollers, Power & Discrete and Imaging.
On a year-over-year basis, EMEA revenues decreased 32.5%, mainly driven by lower sales in General-Purpose Microcontrollers, ADAS & Infotainment and Power & Discrete. Americas revenues decreased 27.6%, mainly due to lower sales in General-Purpose Microcontrollers and Power & Discrete. Asia Pacific revenues decreased 20.8%, mainly due to lower sales in General-Purpose Microcontrollers, Power & Discrete and Imaging.
Gross profit
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions) | | | | |
Gross profit | | $ | 1,296 | | | $ | 1,444 | | | $ | 2,119 | | | (10.2) | % | | (38.9) | % |
Gross margin (as percentage of net revenues) | | 40.1 | % | | 41.7 | % | | 49.0 | % | | -160 bps | | -890 bps |
In the second quarter of 2024, gross margin was 40.1%, in line with the mid-point of the outlook range. On a sequential and on a year-over-year basis, gross margin decreased 160 basis points and 890 basis points respectively, mainly due to the combination of product mix and sales price and higher unused capacity charges.
Operating expenses
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | Variation |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 | | Sequential | | Year Over Year |
| | (In millions) | | | | |
Selling, general and administrative expenses | | $ | (419) | | | $ | (425) | | | $ | (414) | | | 1.4 | % | | (1.3) | % |
Research and development expenses | | $ | (535) | | | $ | (528) | | | $ | (555) | | | (1.3) | | | 3.7 | |
Total operating expenses | | $ | (954) | | | $ | (953) | | | $ | (969) | | | (0.1) | % | | 1.6 | % |
As percentage of net revenues | | 29.5 | % | | 27.5 | % | | 22.4 | % | | 200 bps | | 710 bps |
On a sequential basis, operating expenses remained substantially flat. On a year-over-year basis, operating expenses decreased by $15 million, mainly due to the negative non-recurring non-cash items that occurred in the year-ago quarter.
As a percentage of net revenues, our operating expenses amounted to 29.5% in the second quarter of 2024, increasing compared to 27.5% and 22.4% in the prior and year-ago quarters, respectively.
R&D expenses were net of research tax credits, which amounted to $34 million in the second quarter of 2024, compared to $34 million and $36 million, in the prior and year-ago quarters, respectively.
Other income and expenses, net
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Public funding | | $ | 58 | | | $ | 93 | | | $ | 27 | |
Exchange gains (losses), net | | (1) | | | (1) | | | 3 | |
Start-up costs | | (22) | | | (30) | | | (34) | |
Patent costs | | (1) | | | (1) | | | (2) | |
Gain on sale of non-current assets | | 1 | | | 2 | | | 4 | |
| | | | | | |
Other, net | | (2) | | | (3) | | | (2) | |
Other income and expenses, net | | $ | 33 | | | $ | 60 | | | $ | (4) | |
As percentage of net revenues | | 1.0 | % | | 1.7 | % | | (0.1) | % |
Other income and expenses, net, amounted to $33 million income, decreasing by $27 million sequentially due to lower publing funding and increasing by $37 million on a year-over-year basis due to higher public funding.
Operating income
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Operating income | | $ | 375 | | | $ | 551 | | | $ | 1,146 | |
As percentage of net revenues | | 11.6 | % | | 15.9 | % | | 26.5 | % |
In the second quarter of 2024, operating income was $375 million, compared to an operating income of $551 million and $1,146 million in the prior and year-ago quarters, respectively.
On a sequential and year-over-year basis, operating income was mainly impacted by decreased gross margin profitability.
Operating income by reportable segment
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | $ million | | % of net revenues | | $ million | | % of net revenues | | $ million | | % of net revenues |
AM&S segment | | $ | 144 | | | 12.4 | % | | $ | 185 | | | 15.2 | % | | $ | 259 | | | 20.0 | % |
P&D segment | | 110 | | | 14.7 | | | 138 | | | 16.8 | | | 262 | | | 26.4 | |
Analog, Power & Discrete, MEMS and Sensors Group (APMS) | | 254 | | | 13.3 | | | 323 | | | 15.8 | | | 521 | | | 22.8 | |
MCU segment | | 72 | | | 8.9 | | | 185 | | | 19.5 | | | 551 | | | 37.2 | |
D&RF segment | | 150 | | | 29.1 | | | 150 | | | 31.8 | | | 196 | | | 35.2 | |
Microcontrollers, Digital ICs and RF products Group (MDRF) | | 222 | | | 16.8 | | | 335 | | | 23.6 | | | 747 | | | 36.6 | |
Total operating income of operating segments | | 476 | | | 14.7 | | | 658 | | | 19.0 | | | 1,268 | | | 29.3 | |
Others(1) | | (101) | | | — | | | (107) | | | — | | | (122) | | | — | |
Total consolidated operating income | | $ | 375 | | | 11.6 | % | | $ | 551 | | | 15.9 | % | | $ | 1,146 | | | 26.5 | % |
(1)Operating income (loss) of Others include items such as unused capacity charges, including incidents leading to power outage, impairment and restructuring charges, management reorganization costs, start-up and phase out costs, and other unallocated income (expenses) such as: strategic or special research and development programs, certain corporate-level operating expenses, patent claims
and litigations, and other costs that are not allocated to reportable segments (e.g. urgent freight costs, changes in fair value measurement on contingent consideration liabilities), as well as operating earnings of other products.
For the second quarter of 2024, AM&S operating income was $144 million, decreasing sequentially by $41 million, mainly driven by lower profitability in Analog Products. P&D operating income was $110 million, decreasing sequentially by $28 million. MCU operating income decreased by $113 million sequentially, mainly driven by General-Purpose Microcontrollers and Auto Processing & RF lower profitability. D&RF operating income remained substantially flat.
AM&S operating income decreased by $115 million year-over-year reflecting lower profitability mainly in Analog Products and MEMS. P&D operating income decreased by $152 million. MCU operating income decreased by $479 million, with General-Purpose Microcontrollers, Auto Processing & RF and Connected Security decreasing. D&RF operating income decreased by $46 million, mainly driven by ADAS & Infotainment lower profitability.
Reconciliation to consolidated operating income
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Total operating income of reportable segments | | $ | 476 | | | $ | 658 | | | $ | 1,268 | |
Impairment loss on intangible assets acquired through business combinations | | — | | | — | | | (36) | |
Start-up costs | | (22) | | | (30) | | | (34) | |
Unused capacity charges | | (84) | | | (63) | | | (15) | |
Contingent consideration fair value measurement | | — | | | — | | | 5 | |
Other unallocated manufacturing results | | 10 | | | (10) | | | (9) | |
Gain on sale of non-current assets | | — | | | 1 | | | 3 | |
Strategic and R&D programs and other non-allocated provisions(1) | | (5) | | | (5) | | | (36) | |
Total operating income (loss) of Others | | (101) | | | (107) | | | (122) | |
Total consolidated operating income | | $ | 375 | | | $ | 551 | | | $ | 1,146 | |
(1)Includes unallocated income and expenses such as certain corporate-level operating expenses and other income (costs) that are not allocated to the reportable segments.
Interest income, net
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Interest income, net | | $ | 51 | | | $ | 59 | | | $ | 33 | |
In the second quarter of 2024, we recorded a net interest income of $51 million, compared to a net interest income of $59 million in the prior quarter and a net interest income of $33 million in the year-ago quarter. Net interest income was composed of $76 million of interest income, partially offset by interest expense on borrowings and banking fees of $25 million. The year-over-year increase in interest income was mainly due to higher investments in short-term deposits and marketable securities and higher U.S dollar interest yields.
Income tax expense
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Income tax expense | | $ | (67) | | | $ | (92) | | | $ | (171) | |
During the second quarter of 2024, we registered an income tax expense of $67 million, reflecting a 16.9% estimated annual effective tax rate before discrete items at consolidated level, applied to the first six months of 2024 consolidated income before income tax. The estimated annual effective tax rate 2024 includes the estimated impact of Pillar Two taxes for 2024 for 0.5% and explain, together with the variation in the profit mix the increase compared to the 15% actual annual effective tax rate for 2023 before discrete items.
Net income attributable to parent company
| | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended |
| | June 29, 2024 | | March 30, 2024 | | July 1, 2023 |
| | (In millions) |
Net income attributable to parent company | | $ | 353 | | | $ | 513 | | | $ | 1,001 | |
As percentage of net revenues | | 10.9 | % | | 14.8 | % | | 23.1 | % |
For the second quarter of 2024, we reported net income of $353 million, representing diluted earnings per share of $0.38, compared to $0.54 in the prior quarter and $1.06 in the prior-year quarter.
Six Months of 2024 vs. Six Months of 2023
The following table sets forth certain financial data from our Unaudited Interim Consolidated Statements of Income:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | $ million | | % of net revenues | | $ million | | % of net revenues |
Net sales | | $ | 6,670 | | | 99.6 | % | | $ | 8,561 | | | 99.9 | % |
Other revenues | | 27 | | | 0.4 | | | 12 | | | 0.1 | |
Net revenues | | 6,697 | | | 100.0 | | | 8,573 | | | 100.0 | |
Cost of sales | | (3,958) | | | (59.1) | | | (4,344) | | | (50.7) | |
Gross profit | | 2,739 | | | 40.9 | | | 4,229 | | | 49.3 | |
Selling, general and administrative expenses | | (844) | | | (12.6) | | | (808) | | | (9.4) | |
Research and development expenses | | (1,063) | | | (15.9) | | | (1,060) | | | (12.4) | |
Other income and expenses, net | | 93 | | | 1.4 | | | (14) | | | (0.2) | |
| | | | | | | | |
Operating income | | 925 | | | 13.8 | | | 2,347 | | | 27.4 | |
Interest income, net | | 111 | | | 1.7 | | | 70 | | | 0.8 | |
Other components of pension benefit costs | | (8) | | | (0.1) | | | (9) | | | (0.1) | |
Loss on financial instruments, net | | (1) | | | — | | | — | | | — | |
Income before income taxes and noncontrolling interest | | 1,027 | | | 15.3 | | | 2,408 | | | 28.1 | |
Income tax expense | | (159) | | | (2.4) | | | (359) | | | (4.2) | |
Net income | | 868 | | | 13.0 | | | 2,049 | | | 23.9 | |
Net income attributable to noncontrolling interest | | (3) | | | — | | | (4) | | | — | |
Net income attributable to parent company | | $ | 865 | | | 12.9 | % | | $ | 2,045 | | | 23.9 | % |
Net revenues
| | | | | | | | | | | | | | | | | | | | |
| | Six Months ended | | |
| | June 29, 2024 | | July 1, 2023 | | % Variation |
| | (In millions) |
Net sales | | $ | 6,670 | | | $ | 8,561 | | | (22.1) | % |
Other revenues | | 27 | | | 12 | | | 131.6 | |
Net revenues | | $ | 6,697 | | | $ | 8,573 | | | (21.9) | % |
Our first six months 2024 net revenues decreased 21.9% compared to the year-ago period, as a result of an approximate 13% decrease in average selling prices, due to a less favorable product mix and lower selling prices, and a decrease in volumes of approximately 9%.
Net revenues by reportable segment
| | | | | | | | | | | | | | | | | | | | |
| | Six Months ended | | |
| | June 29, 2024 | | July 1, 2023 | | % Variation |
| | (In millions) | | |
AM&S segment | | $ | 2,382 | | | $ | 2,693 | | | (11.6) | % |
P&D segment | | 1,567 | | | 1,898 | | | (17.4) | |
Analog, Power & Discrete, MEMS and Sensors Group (APMS) | | 3,949 | | | 4,591 | | | (14.0) | |
MCU segment | | 1,750 | | | 2,930 | | | (40.3) | |
D&RF segment | | 990 | | | 1,044 | | | (5.1) | |
Microcontrollers, Digital ICs and RF products Group (MDRF) | | 2,740 | | | 3,974 | | | (31.0) | |
Others | | 8 | | | 8 | | | (8.2) | |
Total consolidated net revenues | | $ | 6,697 | | | $ | 8,573 | | | (21.9) | % |
By reportable segment, AM&S revenues were down 11.6%, with lower average selling prices of approximately 6%, due to lower selling prices, and a decrease in volumes of approximately 6%. P&D revenues decreased 17.4%, due to lower volumes of approximately 11%, and lower average selling prices of approximately 6% mainly due to lower selling prices. MCU revenues decreased 40.3% compared to the prior-year period, driven by lower average selling prices of approximately 21%, due to a less favorable product mix and lower selling prices, and by lower volumes of approximately 19%. D&RF revenues decreased 5.1% compared to the prior-year period, mainly due to lower average selling prices linked to a less favorable product mix.
Net Revenues by Market Channel (1)
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
OEM | | 71 | % | | 64 | % |
Distribution | | 29 | | | 36 | |
Total | | 100 | % | | 100 | % |
(1)OEM are the end-customers to which we provide direct marketing application engineering support, while Distribution refers to the distributors and representatives that we engage to distribute our products around the world.
By market channel, distribution decreased to a 29% share of total revenues in the first six months of 2024, compared to 36% in the first six months of 2023.
Net Revenues by Location of Shipment(1)
| | | | | | | | | | | | | | | | | | | | |
| | Six Months ended | | |
| | June 29, 2024 | | July 1, 2023 | | % Variation |
| | (In millions) | | |
EMEA | | $ | 1,793 | | | $ | 2,430 | | | (26.2) | % |
Americas | | 1,025 | | | 1,385 | | | (26.0) | |
Asia Pacific | | 3,879 | | | 4,758 | | | (18.5) | |
Total consolidated net revenues | | $ | 6,697 | | | $ | 8,573 | | | (21.9) | % |
(1)Net revenues by location of shipment are classified by location of customer invoiced or reclassified by shipment destination in line with customer demand. For example, products ordered by U.S. based companies to be invoiced to Asia Pacific affiliates are classified as Asia Pacific revenues. Furthermore, the comparison among the different periods may be affected by shifts in shipments from one location to another, as requested by our customers.
By location of shipment, EMEA revenues decreased by 26.2%, mainly driven by lower sales in General-Purpose Microcontrollers, ADAS & Infotainment and Power & Discrete. Americas revenues decreased 26.0%, mainly due to lower sales in General-Purpose Microcontrollers and Power Discrete. Asia Pacific revenues decreased 18.5%, mainly due to lower sales in General-Purpose Microcontrollers, Imaging and Power Discrete.
Gross profit
| | | | | | | | | | | | | | | | | | | | |
| | Six Months ended | | |
| | June 29, 2024 | | July 1, 2023 | | Variation |
| | (In millions) | | |
Gross profit | | $ | 2,739 | | | $ | 4,229 | | | (35.2) | % |
Gross margin (as percentage of net revenues) | | 40.9 | % | | 49.3 | % | | 840 bps |
Gross margin was 40.9% for the first six months of 2024, decreasing by approximately 840 basis points compared to the year-ago period, mainly due to the combination of sales price and product mix and higher unused capacity charges.
Operating expenses
| | | | | | | | | | | | | | | | | | | | |
| | Six Months ended | | |
| | June 29, 2024 | | July 1, 2023 | | Variation |
| | (In millions) | | |
Selling, general and administrative expenses | | $ | (844) | | | $ | (808) | | | (4.4) | % |
Research and development expenses | | (1,063) | | | (1,060) | | | (0.2) | |
Total operating expenses | | $ | (1,907) | | | $ | (1,868) | | | (2.0) | % |
As percentage of net revenues | | 28.5 | % | | 21.8 | % | | 670 bps |
Our operating expenses increased compared to the year-ago period, mainly due to higher cost of labor and increased R&D activity.
As a percentage of net revenues, our operating expenses amounted to 28.5%, increasing from 21.8% in the year-ago period.
Total R&D expenses were net of research tax credits, which amounted to $68 million in the first six months of 2024 compared to $66 million in the first six months of 2023.
Other income and expenses, net
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Public funding | | $ | 151 | | | $ | 52 | |
Exchange gains (losses), net | | (2) | | | 3 | |
Start-up costs | | (52) | | | (67) | |
Patent costs | | (3) | | | (5) | |
Gain on sale of non-current assets | | 3 | | | 5 | |
| | | | |
Other, net | | (4) | | | (2) | |
Other income and expenses, net | | $ | 93 | | | $ | (14) | |
As percentage of net revenues | | 1.4 | % | | (0.2) | % |
In the first six months of 2024, other income and expenses, net, amounted to a $93 million income, increasing by $107 million from $14 million expense during the first six months of 2023, due to higher income from public funding.
Operating income
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Operating income | | $ | 925 | | | $ | 2,347 | |
As percentage of net revenues | | 13.8 | % | | 27.4 | % |
Operating income in the first six months of 2024 decreased by $1,422 million to $925 million, compared to the prior-year period, mainly due to a decrease in gross margin profitability.
Operating income by reportable segments
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | $ million | | % of net revenues | | $ million | | % of net revenues |
AM&S segment | | $ | 328 | | | 13.8 | % | | $ | 593 | | | 22.0 | % |
P&D segment | | 248 | | | 15.8 | | | 498 | | | 26.2 | |
Analog, Power & Discrete, MEMS and Sensors Group (APMS) | | 576 | | | 14.6 | | | 1,091 | | | 23.8 | |
MCU segment | | 256 | | | 14.6 | | | 1,106 | | | 37.7 | |
D&RF segment | | 301 | | | 30.4 | | | 361 | | | 34.6 | |
Microcontrollers, Digital ICs and RF products Group (MDRF) | | 557 | | | 20.3 | | | 1,467 | | | 36.9 | |
Total operating income of operating segments | | 1,133 | | | 16.9 | | | 2,558 | | | 29.8 | |
Others(1) | | (208) | | | — | | | (211) | | | — | |
Total consolidated operating income | | $ | 925 | | | 13.8 | % | | $ | 2,347 | | | 27.4 | % |
(1)Operating income (loss) of Others include items such as unused capacity charges, including incidents leading to power outage, impairment and restructuring charges, management reorganization costs, start-up and phase out costs, and other unallocated income (expenses) such as: strategic or special research and development programs, certain corporate-level operating expenses, patent claims and litigations, and other costs that are not allocated to reportable segments (e.g. urgent freight costs, changes in fair value measurement on contingent consideration liabilities), as well as operating earnings of other products.
In the first six months of 2024, AM&S operating income decreased by $265 million to $328 million, with lower profitability in both Analog and MEMS. P&D operating income was $248 million, decreasing by $250 million. MCU operating income was $256 million, lower by $850 million with General-Purpose Microcontrollers, Auto Processing & RF and Connected Security decreasing. D&RF operating income amounted to $301 million, decreasing by $60 million mainly due to lower profitability in ADAS & Infotainment.
Reconciliation to consolidated operating income
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Total operating income of reportable segments | | $ | 1,133 | | | $ | 2,558 | |
Impairment loss on intangible assets acquired through business combinations | | — | | | (36) | |
Start-up costs | | (52) | | | (67) | |
Unused capacity charges | | (147) | | | (16) | |
Contingent consideration fair value measurement | | — | | | 5 | |
Other unallocated manufacturing results | | — | | | (61) | |
Gain on sale of non-current assets | | 1 | | | 4 | |
Strategic and R&D programs and other non-allocated provisions(1) | | (10) | | | (40) | |
Total operating income (loss) of Others | | (208) | | | (211) | |
Total consolidated operating income | | $ | 925 | | | $ | 2,347 | |
(1)Includes unallocated income and expenses such as certain corporate-level operating expenses and other income (costs) that are not allocated to the reportable segments.
Interest income, net
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Interest income, net | | $ | 111 | | | $ | 70 | |
In the first six months of 2024, we recorded a net interest income of $111 million, compared to $70 million in the year-ago period. The first six months of 2024 net interest income was composed of $157 million of interest income, partially offset by interest expense on borrowings and banking fees of $46 million. The increase in interest income was mainly due to higher investments in short-term deposits and marketable securities and higher U.S dollar interest yields.
Income tax expense
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Income tax expense | | $ | (159) | | | $ | (359) | |
During the first six months of 2024, we registered an income tax expense of $159 million, reflecting a 16.9% estimated annual effective tax rate before discrete items at consolidated level, applied to the first six months of 2024 consolidated profit before tax. The estimated annual effective tax rate 2024 includes the estimated impact of Pillar Two taxes for 2024 for 0.5%.
In the first six months of 2023, we registered an income tax expense of $359 million.
Our tax rate is variable and depends on changes in the level of operating results within various local jurisdictions and on changes in the applicable taxation rates of these jurisdictions, as well as changes in estimates on our tax provisions. For 2024, it also takes into account the estimated impact of Pillar Two taxes. Our income tax amounts and rates also depend on our loss carry-forwards and their relevant valuation allowance, which are based on estimated projected plans and available tax planning strategies. In the case of material changes in these plans, the valuation allowance could be adjusted accordingly, with an impact on our income tax expense. In
addition, our annual income tax expense includes the estimated impact of provisions related to potential tax positions which have been considered as uncertain.
Net income attributable to parent company
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Net income attributable to parent company | | $ | 865 | | | $ | 2,045 | |
As percentage of net revenues | | 12.9 | % | | 23.9 | % |
For the first six months of 2024, we reported net income of $865 million, representing diluted earnings per share of $0.92, compared to a net income of $2,045 million in the prior period, representing diluted earnings per share of $2.16.
Legal Proceedings
For a discussion of legal proceedings, see Note 27 Contingencies, Claims and Legal Proceedings to our Consolidated Financial Statements.
Impact of Changes in Exchange Rates
Our results of operations and financial condition can be significantly affected by material changes in the exchange rates between the U.S. dollar and other currencies, particularly the Euro.
As a market practice, the reference currency for the semiconductor industry is the U.S. dollar and the market prices of semiconductor products are mainly denominated in U.S. dollars. However, revenues for some of our products are quoted in currencies other than the U.S. dollar, such as Euro-denominated sales, and consequently are directly affected by fluctuations in the value of the U.S. dollar. As a result of currency variations, the appreciation of the Euro compared to the U.S. dollar could increase our level of revenues when translated into U.S. dollars or the depreciation of the Euro compared to the U.S. dollar could decrease our level of revenues when reported in U.S. dollars. Over time and depending on market conditions, the prices in the industry could align to the equivalent amount in U.S. dollars, except that there is a lag between the changes in the currency rate and the adjustment in the price paid in local currency, which is proportional to the amplitude of the currency swing, and such adjustment could be only partial and/or delayed, depending on market demand. Furthermore, certain significant costs incurred by us, such as manufacturing costs, SG&A expenses and R&D expenses, are largely incurred in the currency of the jurisdictions in which our operations are located. Given that most of our operations are located in the Eurozone and other non-U.S. dollar currency areas, including Singapore, our costs tend to increase when translated into U.S. dollars when the U.S. dollar weakens, or to decrease when the U.S. dollar strengthens.
Our principal strategy to reduce the risks associated with exchange rate fluctuations is to balance as much as possible the proportion of sales to our customers denominated in U.S. dollars with the amount of materials, purchases and services from our suppliers denominated in U.S. dollars, thereby reducing the potential exchange rate impact of certain variable costs relative to revenues. Moreover, in order to further reduce the exposure to U.S. dollar exchange fluctuations, we hedge certain line items on our Consolidated Statements of Income, in particular with respect to a portion of cost of sales, most of R&D expenses and certain SG&A expenses, located in the Eurozone, which we designate as cash flow hedge transactions. We use two different types of hedging instruments: forward contracts and currency options (including collars).
Our Unaudited Interim Consolidated Statement of Income for the six months ended June 29, 2024 included income and expense items translated at the average U.S. dollar exchange rate for the period, plus the impact of the hedging contracts settled during the period. Our effective average exchange rate for the second quarter of 2024 was $1.08 for €1.00, compared to $1.09 for €1.00 in the first quarter of 2024 and $1.08 for €1.00 in the second quarter of 2023. These effective exchange rates reflect the actual exchange rates combined with the effect of cash flow hedge transactions impacting earnings in the period.
The time horizon of our cash flow hedging for manufacturing costs and operating expenses may run up to 24 months, for a limited percentage of our exposure to the Euro, depending on currency market conditions. As of June 29, 2024, the outstanding hedged amounts were €1,490 million to cover manufacturing costs and €740 million to cover operating expenses, at an average exchange rate of approximately $1.10 for €1.00 (considering the collars at upper strike), maturing from July 3, 2024 to April 30, 2025. As of June 29, 2024, measured in respect to the exchange rate at period closing of about $1.07 to €1.00, these outstanding hedging contracts and certain settled contracts covering manufacturing expenses capitalized in inventory resulted in a deferred unrealized loss of approximately $13 million before tax, recorded in “Accumulated other comprehensive income (loss)” in the Consolidated Statement of Equity, compared to a deferred unrealized gain of approximately $54 million before tax on December 31, 2023.
We also hedge certain manufacturing costs denominated in Singapore dollars (“SGD”); as of June 29, 2024, the outstanding hedged amounts were SGD 226 million at an average exchange rate of approximately SGD 1.33 to $1.00 maturing from July 3, 2024 to May 29, 2025. As of June 29, 2024, these outstanding hedging contracts resulted in a deferred unrealized loss of approximately $2 million before tax, recorded in “Accumulated other comprehensive income (loss)” in the Consolidated Statement of Equity, compared to a deferred unrealized gain of $3 million dollars on December 31, 2023.
Our cash flow hedging policy is not intended to cover our full exposure and is based on hedging a declining portion of our exposure in the next four quarters. In the second quarter of 2024, as a result of our cash flow hedging, we recycled to earnings a loss of $5 million, of which approximately $4 million impacted cost of sales and $1 million impacted SG&A expenses, while in the comparable quarter of 2023, we recorded a gain of $14 million.
In addition to our cash flow hedging, in order to mitigate potential exchange rate risks on our commercial transactions, we purchase and enter into foreign exchange forward contracts and currency options to cover foreign currency exposure in payables or receivables at our affiliates, which we do not designate for hedge accounting. We may in the future purchase or sell similar types of instruments. See “Item 11. Quantitative and Qualitative Disclosures About Market Risk” in our Form 20-F. Furthermore, we may not predict on a timely basis the amount of future transactions in the volatile industry environment. No assurance may be given that our hedging activities will sufficiently protect us against fluctuations in the value of the U.S. dollar. Consequently, our results of operations have been and may continue to be impacted by fluctuations in exchange rates. The net effect of our consolidated foreign exchange exposure in payables and receivables at our affiliates resulted in a net loss of $1 million recorded in “Other income and expenses, net” in our Consolidated Statement of Income for the second quarter of 2024.
The assets and liabilities of subsidiaries whose functional currency is different from the U.S. dollar reporting currency are, for consolidation purposes, translated into U.S. dollars at the period-end exchange rate. Income and expenses, as well as cash flows, are translated at the average exchange rate for the period. These currency translation effects have been, and may be, significant from period to period since a large part of our assets and liabilities and activities are accounted for in Euros as they are located in jurisdictions where the Euro is the functional currency. Adjustments resulting from the currency translation are recorded directly in equity and are reported as “Accumulated other comprehensive income (loss)” in the Consolidated Statements of Equity. As of June 29, 2024, our outstanding indebtedness was denominated mainly in U.S. dollars and in Euros.
For a more detailed discussion, see Item 3. “Key Information — Risks Related to Our Operations” in our Form 20-F, which may be updated from time to time in our public filings.
Impact of Changes in Interest Rates
Interest rates may fluctuate upon changes in financial market conditions and material changes can affect our earnings and financial condition, since these changes can impact the total interest income received on our cash and cash equivalents, short-term deposits and marketable securities, as well as the total interest expense paid on our financial debt.
Our interest income, net, as reported in our Unaudited Interim Consolidated Statements of Income, is the balance between interest income received from our cash and cash equivalents, short-term deposits and marketable securities, and interest expense recorded on our financial liabilities, including bank fees (including fees on committed credit lines or on the sale without recourse of receivables, if any). Our interest income is dependent upon fluctuations in interest rates, mainly in U.S. dollars and Euros, since we invest primarily on a short-term basis; any increase or decrease in the market interest rates would mean a proportional increase or decrease in our interest income. Our interest expenses are also dependent upon fluctuations in interest rates,
since our financial liabilities include European Investment Bank (“EIB”) and Cassa Depositi e Prestiti SpA (“CDP SpA”) Floating Rate Loans at Euribor plus variable spreads. See Note 22 to our Consolidated Financial Statements.
As of June 29, 2024, our total financial resources, including cash and cash equivalents, short-term deposits and marketable securities generated an average annual interest rate of 4.81%. At the same date, the average annual interest rate on our outstanding debt was 2.42%.
Impact of Changes in Equity Prices
As of June 29, 2024, we did not hold any significant investments in equity securities with a material exposure to equity price risk. However, on these equity investments, carrying value could be reduced due to further losses or impairment charges. See Note 19 and Note 20 to our Consolidated Financial Statements.
Liquidity and Capital Resources
Treasury activities are regulated by our policies, which define procedures, objectives and controls. Our policies focus on the management of our financial risk in terms of exposure to currency rates and interest rates. Most treasury activities are centralized, with any local treasury activities subject to oversight from our head treasury office. The majority of our cash and cash equivalents are held in U.S. dollars and Euros and are placed with financial institutions rated at least as single A long-term rating from two of the major rating agencies, meaning at least A3 from Moody’s Investors Service (“Moody’s”) and A- from Standard & Poor’s (“S&P”) or Fitch Ratings (“Fitch”). Marginal amounts are held in other currencies. See “Item 11. Quantitative and Qualitative Disclosures About Market Risk” in our Form 20-F, which may be updated from time to time in our public filings.
Cash flow
We maintain an adequate cash position and a low debt-to-equity ratio, to provide us with adequate financial flexibility. As in the past, our cash management policy is to finance our investment needs mainly with net cash generated from operating activities.
During the first six months of 2024, our cash and cash equivalents decreased by $130 million. The components of the net cash variation for the first six months of 2024 and the comparable period are set forth below:
| | | | | | | | | | | | | | |
| | Six Months ended |
| | June 29, 2024 | | July 1, 2023 |
| | (In millions) |
Net cash from operating activities | | $ | 1,561 | | | $ | 2,631 | |
Net cash used in investing activities | | (1,882) | | | (2,400) | |
Net cash from (used in) financing activities | | 196 | | | (380) | |
Effect of changes in exchange rates | | (5) | | | 2 | |
Net cash decrease | | $ | (130) | | | $ | (147) | |
Net cash from operating activities. Net cash from operating activities is the sum of (i) net income adjusted for non-cash items and (ii) changes in net working capital. The net cash from operating activities for the first six months of 2024 was $1,561 million, decreasing compared to $2,631 million in the prior-year period mainly due to lower net income.
Net cash used in investing activities. Investing activities used $1,882 million in the first six months of 2024, decreasing compared to $2,400 million used in the prior-year period, mainly due to lower capital expenditures, net of capital grants and other contributions, proceeds from matured marketable securities, partially offset by higher purchases of marketable securities.
Net cash from (used in) financing activities. Net cash from financing activities was $196 million for the first six months of 2024, compared to net cash used in financing activities of $380 million in the first six months of 2023, and consisted mainly of $300 million proceeds from long-term debt corresponding to the drawdown of the second tranche under our existing €600M credit facility with the EIB, $295 million proceeds from advances on
capital grants, partially offset by $175 million repurchase of common stock, $121 million of dividends paid to stockholders and $95 million repayment of financial debt.
Net Capex and Free Cash Flow (non-U.S. GAAP measures)
We present Net Capex as a non-U.S. GAAP measure, to take into consideration the effect of advances from capital grants received on prior periods allocated to property, plant and equipment in the reporting period. Net Capex is reported as part of our Free Cash Flow (non-U.S. GAAP measure).
Net Capex, a non-U.S. GAAP measure, is defined as (i) Payment for purchase of tangible assets, as reported plus (ii) Proceeds from sale of tangible assets, as reported plus (iii) Proceeds from capital grants and other contributions, as reported plus (iv) Advances from capital grants allocated to property, plant and equipment in the reporting period.
We believe Net Capex provides useful information for investors and management because annual capital expenditures budget includes the effect of capital grants. Our definition of Net Capex may differ from definitions used by other companies.
| | | | | | | | | | | | | | | | | | | | |
| Three Months ended | Six Months ended |
| June 29, 2024 | | | | | June 29, 2024 | | July 1, 2023 |
| (In millions) |
Payment for purchase of tangible assets, as reported | $ | (690) | | | | | | $ | (1,835) | | | $ | (2,204) | |
Proceeds from sale of tangible assets, as reported | 1 | | | | | | 3 | | | 6 | |
Proceeds from capital grants and other contributions, as reported | 143 | | | | | | 292 | | | 37 | |
Advances from capital grants allocated to property, plant and equipment | 18 | | | | | | 45 | | | — | |
Net Capex | $ | (528) | | | | | | $ | (1,495) | | | $ | (2,161) | |
We also present Free Cash Flow, which is a non-U.S. GAAP measure, defined as (i) net cash from operating activities plus (ii) net Capex plus (iii) payment for purchase (and proceeds from sale) of intangible and financial assets and (iv) net cash paid for business acquisitions, if any.
We believe Free Cash Flow provides useful information for investors and management because it measures our capacity to generate cash from our operating and investing activities to sustain our operations.
Free Cash Flow reconciles with the total cash flow and the net cash increase (decrease) by including the payment for purchases of (and proceeds from matured) marketable securities and net investment in (and proceeds from) short-term deposits, the net cash from (used in) financing activities and the effect of changes in exchange rates while excluding the advances from capital grants received in prior periods allocated to property, plant and equipment in the reporting period. Our definition of Free Cash Flow may differ from definitions used by other companies.
Free Cash Flow is determined from our unaudited interim consolidated statements of cash flows as follows:
| | | | | | | | | | | | | | | | | | | | |
| Three Months ended | Six Months ended |
| June 29, 2024 | | | | | June 29, 2024 | | July 1, 2023 |
| (In millions) |
Net cash from operating activities | $ | 702 | | | | | | $ | 1,561 | | | $ | 2,631 | |
Net Capex | (528) | | | | | | (1,495) | | | (2,161) | |
Payment for purchase of intangible assets, net of proceeds from sale | (15) | | | | | | (41) | | | (46) | |
Payment for purchase of financial assets, net of proceeds from sale | — | | | | | | — | | | (8) | |
| | | | | | | | |
Free Cash Flow (non-U.S. GAAP measure) | $ | 159 | | | | | | $ | 25 | | | $ | 416 | |
Free Cash Flow was positive $25 million in the first six months of 2024, compared to positive $416 million in the prior-year period.
Net Financial Position and Adjusted Net Financial Position (non-U.S. GAAP measures)
Our Net Financial Position represents the difference between our total liquidity and our total financial debt. Our total liquidity includes cash and cash equivalents, short-term deposits and marketable securities, and our total financial debt includes short-term debt and long-term debt, as reported in our consolidated balance sheets. Adjusted Net Financial Position represents net financial position less advances from capital grants, to present the effect on total liquidity of advances received on capital grants for which capital expenditures have not been incurred yet. Net Financial Position and Adjusted Net Financial Position are not U.S. GAAP measures, but we believe they provide useful information for investors and management because they give evidence of our global position either in terms of net indebtedness or net cash by measuring our capital resources based on cash and cash equivalents, restricted cash, if any, short-term deposits and marketable securities and the total level of our financial debt. Our definition of Net Financial Position may differ from definitions used by other companies and therefore comparability may be limited. Our Net Financial Position and Adjusted Net Financial Position for each period have been determined from our consolidated balance sheets as follows:
| | | | | | | | | | | | | | | | | | | | |
| | As of |
| | June 29, 2024 | | December 31, 2023 | | July 1, 2023 |
| | (In millions) |
Cash and cash equivalents | | $ | 3,092 | | | $ | 3,222 | | | $ | 3,111 | |
| | | | | | |
Short-term deposits | | 975 | | | 1,226 | | | 106 | |
Marketable securities | | 2,218 | | | 1,635 | | | 1,346 | |
Total liquidity | | 6,285 | | | 6,083 | | | 4,563 | |
Short-term debt | | (236) | | | (217) | | | (176) | |
Long-term debt | | (2,850) | | | (2,710) | | | (2,473) | |
Total financial debt | | (3,086) | | | (2,927) | | | (2,649) | |
Net Financial Position (non-U.S. GAAP measure) | | $ | 3,199 | | | $ | 3,156 | | | $ | 1,914 | |
Advances from capital grants | | (402) | | | (152) | | | — | |
Adjusted Net Financial Position (non-U.S. GAAP measure) | | $ | 2,797 | | | $ | 3,004 | | | $ | 1,914 | |
Our Net Financial Position as of June 29, 2024, was $3,199 million, increasing compared to $3,156 million and $1,914 million as of December 31, 2023 and July 1, 2023 respectively.
Cash and cash equivalents amounted to $3,092 million as of June 29, 2024.
Short-term deposits amounted to $975 million as of June 29, 2024 and consisted of available liquidity with maturity over three months and below one year.
Marketable securities amounted to $2,218 million and consisted of U.S. Treasury Bonds and U.S. Treasury Bills classified as available-for-sale financial assets.
Financial debt was $3,086 million as of June 29, 2024 and was composed of (i) $236 million of short-term debt and (ii) $2,850 million of long-term debt. The breakdown of our total financial debt included (i) $1,280 million in EIB loans, (ii) $244 million in CDP SpA loans, (iii) $1,497 million in our 2020 Senior Unsecured Convertible Bonds, (iv) $61 million in finance leases, and (v) $4 million in loans from other funding programs.
The EIB loans are comprised of three long-term amortizing credit facilities as part of R&D funding programs. The first, signed in August 2017, is a €500 million loan, in relation to R&D and capital expenditures in the European Union, fully drawn in Euros, of which $267 million was outstanding as of June 29, 2024. The second one, signed in 2020, is a €500 million credit facility agreement with EIB to support R&D and capital expenditure programs in Italy and France. The amount was fully drawn in Euros representing $392 million outstanding as of June 29, 2024. In 2022, we signed a third long-term amortizing credit facility with EIB of €600 million, out of which, €300 million was withdrawn in Euros and $300 million in U.S Dollars, representing $621 million outstanding as of June 29, 2024.
The CDP SpA loans are comprised of two long-term credit facilities. The first, signed in 2021, is a €150 million loan, fully drawn in Euros, of which $80 million were outstanding as of June 29, 2024. The second one, signed in 2022, is a €200 million loan, fully drawn in Euros, of which $164 million were outstanding as of June 29, 2024.
On August 4, 2020, we issued a $1.5 billion offering of senior unsecured convertible bonds convertible into new or existing ordinary shares of the Company. The 2020 Senior Unsecured Convertible Bonds were issued in two $750 million principal amount tranches, Tranche A with a maturity of 5 years (47.5% conversion premium, negative 1.12% yield to maturity, 0% coupon) and Tranche B with a maturity of 7 years (52.5% conversion premium, negative 0.63% yield to maturity, 0% coupon). The conversion price is $43.62 on Tranche A and $45.10 on Tranche B. The 2020 Senior Unsecured Convertible Bonds are convertible by the bondholders if certain conditions are satisfied, on a net-share settlement basis, except if we elect a full-cash or a full-share conversion as an alternative settlement. Proceeds from the issuance of the bonds, net of $10 million transaction costs, amounted to $1,567 million. Long-term debt as of June 29, 2024 was reported at $1,497 million which reflects the nominal value of the 2020 senior unsecured convertible bonds less $3 million unamortized debt issuance costs.
Our long-term debt contains standard conditions but does not impose minimum financial ratios. We had unutilized committed medium-term credit facilities with core relationship banks totaling $691 million as of June 29, 2024.
As of June 29, 2024, debt payments at redemption value by period were as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Payments Due by Period |
| | Total | | 2024 | | 2025 | | 2026 | | 2027 | | 2028 | | Thereafter |
| | (In millions) |
Long-term debt (including current portion) | | $ | 3,089 | | | $ | 236 | | | $ | 985 | | | $ | 233 | | | $ | 957 | | | $ | 214 | | | $ | 464 | |
In the above table, our 2020 Senior Unsecured Convertible Bonds are presented at their principal amount with original maturity date of 2025 for Tranche A and 2027 for Tranche B, in line with contractual terms.
Our current ratings with the two major rating agencies that report on us on a solicited basis, are as follows: S&P: “BBB+” with stable outlook; Moody’s: “Baa1” with positive outlook.
Financial Outlook: Capital Investment
Our policy is to modulate our capital spending according to the evolution of the semiconductor market. We plan our Net Capex (non-U.S. GAAP measure) plan for 2024 at about $2.5 billion focusing on our strategic manufacturing initiatives.
A large portion of Net Capex1 will be devoted to support our strategic programs, selected capacity additions and mix change in our manufacturing footprint, in particular for our wafer fabs:
•the increase capacity for silicon carbide products in our Catania and Singapore fabs;
•the ramp-up of a new integrated silicon carbide substrate manufacturing facility in Catania for the production in volume of 150mm, moving to 200mm, silicon carbide epitaxial substrates;
•the creation of new 200mm silicon carbide device manufacturing joint venture with Sanan Optoelectronics in Chongqing, China;
•the ramp-up of our new 300mm wafer fab in Agrate, Italy, to support mixed signal technologies and then phase-in smart power technologies and embedded-non-volatile memory at a later stage;
•digital 300mm in Crolles, France, to extend the cleanroom and support production ramp-up of our main runner technologies;
•certain selected programs of capacity growth in some of our most advanced 200mm fabs, including the analog 200mm fab in Singapore.
The most important 2024 capital investments for our back-end facilities will be: (i) capacity growth on certain package families, including PLP / Direct Copper Interconnect technology and automotive related packages, (ii) the new generation of Intelligent Power Modules for Automotive and Industrial applications, and (iii) specific investments in innovative assembly processes and test operations.
The remaining part of our capital investment plan covers the overall maintenance and efficiency improvements of our manufacturing operations and infrastructure, R&D activities, laboratories as well as the execution of our carbon neutrality programs.
We will continue to invest to support revenues growth and new products introduction, taking into consideration factors such as trends in the semiconductor industry, capacity utilization and our goal to become carbon neutral by 2027 on scope 1 and 2 and partially scope 3. We expect to need significant financial resources in the coming years for capital expenditures and for our investments in manufacturing and R&D. We plan to fund our capital requirements with cash provided by operating activities, available funds and support from third parties, and may have recourse to borrowings under available credit lines and, to the extent necessary or attractive based on market conditions prevailing at the time, the issuance of debt, convertible bonds or additional equity securities. A substantial deterioration of our economic results, and consequently of our profitability, could generate a deterioration of the cash generated by our operating activities. Therefore, there can be no assurance that, in future periods, we will generate the same level of cash as in prior-years to fund our capital expenditure plans for expanding/upgrading our production facilities, our working capital requirements, our R&D and manufacturing costs.
We believe that we have the financial resources needed to meet our currently projected business requirements for the next twelve months, including capital expenditures for our manufacturing activities, working capital requirements, approved dividend payments, share buy-backs as part of our current repurchase program and the repayment of our debt in line with maturity dates.
We will now drive the Company based on a revised plan for 2024 revenues in the range of $13.2 billion to $13.7 billion. Within this plan, we expect a gross margin of about 40%.
Contractual Obligations, Commercial Commitments and Contingencies
Our contractual obligations, commercial commitments and contingencies are mainly comprised of: long-term purchase commitments for material, equipment and software license, take-or-pay type of agreements to outsource wafers from foundries, and firm contractual commitments related to power purchase and minimum energy efficiency, as part of our actions to become carbon neutral by 2027 on scope 1 and 2 and partially scope 3, commercial agreements with customers, long term debt obligations, pension obligations and other long-term liabilities.
Off-Balance Sheet Arrangements
We had no material off-balance sheet arrangements as of June 29, 2024.
Impact of Recently Issued U.S. Accounting Standards
See Note 5 Recent Accounting Pronouncements to our Consolidated Financial Statements.
Backlog and Customers
During the second quarter of 2024, our booking plus net frame orders decreased compared to the first quarter of 2024. We entered the third quarter of 2024 with a backlog lower than the level we had when entering in the second quarter of 2024. Backlog (including frame orders) is subject to possible cancellation, push back and lower ratio of frame orders being translated into firm orders and, thus, it is not necessarily indicative of the amount of billings or growth to be registered in subsequent periods.
There is no guarantee that any customer will continue to generate revenues for us at the same levels as in prior periods. If we were to lose one or more of our key customers, or if they were to significantly reduce their bookings, not confirm planned delivery dates on frame orders in a significant manner or fail to meet their payment obligations, our operating results and financial condition could be adversely affected.
Disclosure Controls and Procedures
Evaluation
Our management, including the CEO and CFO, performed an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (“Disclosure Controls”) as of the end of the period covered by this report. Disclosure Controls are controls and procedures designed to reasonably assure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, (as amended, the “Exchange Act”), such as this periodic report, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure Controls are also designed to reasonably assure that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our quarterly evaluation of Disclosure Controls includes an evaluation of certain components of our internal control over financial reporting, and internal control over financial reporting is also separately evaluated on an annual basis.
The evaluation of our Disclosure Controls included a review of the controls’ objectives and design, our implementation of the controls and their effect on the information generated for use in this periodic report. In the course of the controls evaluation, we reviewed identified data errors, errors in process flow or delay in communication, control problems and sought to confirm that appropriate corrective actions, including process improvements, were being undertaken. This type of evaluation is performed at least on a quarterly basis so that the conclusions of management, including the CEO and CFO, concerning the effectiveness of the Disclosure Controls can be reported in our periodic reports on Form 6-K and Form 20-F. The components of our Disclosure Controls are also evaluated on an ongoing basis by our Internal Audit Department, which reports directly to our Audit Committee. The overall goals of these various evaluation activities are to monitor our Disclosure Controls, and to modify them as necessary. Our intent is to maintain the Disclosure Controls as dynamic systems that change as conditions warrant.
Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this periodic report, our Disclosure Controls were effective.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls
No system of internal control over financial reporting, including one determined to be effective, may prevent or detect all misstatements. It can provide only reasonable assurance regarding financial statement preparation and presentation. Also, projections of the results of any evaluation of the effectiveness of internal control over financial reporting into future periods are subject to inherent risk that the relevant controls may become inadequate due to changes in circumstances or that the degree of compliance with the underlying policies or procedures may deteriorate.
Other Reviews
We have sent this report to our Audit Committee, which had an opportunity to raise questions with our management and independent auditors before we submitted it to the Securities and Exchange Commission.
Cautionary Note Regarding Forward-Looking Statements
Some of the statements contained in this Form 6-K that are not historical facts, particularly in “Business Overview” and in “Liquidity and Capital Resources—Financial Outlook: Capital Investment”, are statements of future expectations and other forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 or Section 21E of the Securities Exchange Act of 1934, each as amended) that are based on management’s current views and assumptions, and are conditioned upon and also involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those anticipated by such statements due to, among other factors:
•Changes in global trade policies, including the adoption and expansion of tariffs and trade barriers, that could affect the macro-economic environment and adversely impact the demand for our products;
•Uncertain macro-economic and industry trends (such as inflation and fluctuations in supply chains), which may impact production capacity and end-market demand for our products;
•Customer demand that differs from projections;
•The ability to design, manufacture and sell innovative products in a rapidly changing technological environment;
•Changes in economic, social, public health, labor, political, or infrastructure conditions in the locations where we, our customers, or our suppliers operate, including as a result of macro-economic or regional events, geopolitical and military conflicts, social unrest, labor actions, or terrorist activities;
•Unanticipated events or circumstances, which may impact our ability to execute our plans and/or meet the objectives of our R&D and manufacturing programs, which benefit from public funding;
•Financial difficulties with any of our major distributors or significant curtailment of purchases by key customers;
•The loading, product mix, and manufacturing performance of our production facilities and/or our required volume to fulfill capacity reserved with suppliers or third-party manufacturing providers;
•Availability and costs of equipment, raw materials, utilities, third-party manufacturing services and technology, or other supplies required by our operations (including increasing costs resulting from inflation);
•The functionalities and performance of our IT systems, which are subject to cybersecurity threats and which support our critical operational activities including manufacturing, finance and sales, and any breaches of our IT systems or those of our customers, suppliers, partners and providers of third-party licensed technology;
•Theft, loss, or misuse of personal data about our employees, customers, or other third parties, and breaches of data privacy legislation;
•The impact of intellectual property (“IP”) claims by our competitors or other third parties, and our ability to obtain required licenses on reasonable terms and conditions;
•Changes in our overall tax position as a result of changes in tax rules, new or revised legislation, the outcome of tax audits or changes in international tax treaties which may impact our results of operations as well as our ability to accurately estimate tax credits, benefits, deductions and provisions and to realize deferred tax assets;
•Variations in the foreign exchange markets and, more particularly, the U.S. dollar exchange rate as compared to the Euro and the other major currencies we use for our operations;
•The outcome of ongoing litigation as well as the impact of any new litigation to which we may become a defendant;
•Product liability or warranty claims, claims based on epidemic or delivery failure, or other claims relating to our products, or recalls by our customers for products containing our parts;
•Natural events such as severe weather, earthquakes, tsunamis, volcano eruptions or other acts of nature, the effects of climate change, health risks and epidemics or pandemics in locations where we, our customers or our suppliers operate;
•Increased regulation and initiatives in our industry, including those concerning climate change and sustainability matters and our goal to become carbon neutral by 2027 on scope 1 and 2 and partially scope 3;
•Epidemics or pandemics, which may negatively impact the global economy in a significant manner for an extended period of time, and could also materially adversely affect our business and operating results;
•Industry changes resulting from vertical and horizontal consolidation among our suppliers, competitors, and customers; and
•The ability to successfully ramp up new programs that could be impacted by factors beyond our control, including the availability of critical third-party components and performance of subcontractors in line with our expectations.
Such forward-looking statements are subject to various risks and uncertainties, which may cause actual results and performance of our business to differ materially and adversely from the forward-looking statements. Certain forward-looking statements can be identified by the use of forward-looking terminology, such as “believes”, “expects”, “may”, “are expected to”, “should”, “would be”, “seeks” or “anticipates” or similar expressions or the negative thereof or other variations thereof or comparable terminology, or by discussions of strategy, plans or intentions.
Some of these risks are set forth and are discussed in more detail in “Item 3. Key Information - Risk Factors” included in our Annual Report on Form 20-F for the year ended December 31, 2023 as filed with the Securities and Exchange Commission (“SEC”) on February 22, 2024. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in our Form 20-F as anticipated, believed or expected. We do not intend, and do not assume any obligation, to update any industry information or forward-looking statements set forth in this Form 6-K to reflect subsequent events or circumstances.
Unfavorable changes in the above or other risks or uncertainties listed under “Item 3. Key Information - Risk Factors” from time to time in our SEC filings, could have a material adverse effect on our business.
STMICROELECTRONICS N.V.
UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF INCOME
| | | | | | | | | | | | | | |
| | Three Months ended |
| | (Unaudited) |
In million of U.S. dollars except per share amounts | | June 29, 2024 | | July 1, 2023 |
Net sales | | 3,227 | | | 4,320 | |
Other revenues | | 5 | | | 6 | |
Net revenues | | 3,232 | | | 4,326 | |
Cost of sales | | (1,936) | | | (2,207) | |
Gross profit | | 1,296 | | | 2,119 | |
Selling, general and administrative expenses | | (419) | | | (414) | |
Research and development expenses | | (535) | | | (555) | |
Other income and expenses, net | | 33 | | | (4) | |
| | | | |
Operating income | | 375 | | | 1,146 | |
Interest income, net | | 51 | | | 33 | |
Other components of pension benefit costs | | (4) | | | (5) | |
Loss on financial instruments, net | | (1) | | | — | |
Income before income taxes and noncontrolling interest | | 421 | | | 1,174 | |
Income tax expense | | (67) | | | (171) | |
Net income | | 354 | | | 1,003 | |
Net income attributable to noncontrolling interest | | (1) | | | (2) | |
Net income attributable to parent company stockholders | | 353 | | | 1,001 | |
| | | | |
Earnings per share (Basic) attributable to parent company's stockholders | | 0.39 | | | 1.11 | |
Earnings per share (Diluted) attributable to parent company's stockholders | | 0.38 | | | 1.06 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF INCOME
| | | | | | | | | | | | | | |
| | Six Months ended |
| | (Unaudited) |
In million of U.S. dollars except per share amounts | | June 29, 2024 | | July 1, 2023 |
Net sales | | 6,670 | | | 8,561 | |
Other revenues | | 27 | | | 12 | |
Net revenues | | 6,697 | | | 8,573 | |
Cost of sales | | (3,958) | | | (4,344) | |
Gross profit | | 2,739 | | | 4,229 | |
Selling, general and administrative expenses | | (844) | | | (808) | |
Research and development expenses | | (1,063) | | | (1,060) | |
Other income and expenses, net | | 93 | | | (14) | |
Operating income | | 925 | | | 2,347 | |
Interest income, net | | 111 | | | 70 | |
Other components of pension benefit costs | | (8) | | | (9) | |
Loss on financial instruments, net | | (1) | | | — | |
Income before income taxes and noncontrolling interest | | 1,027 | | | 2,408 | |
Income tax expense | | (159) | | | (359) | |
Net income | | 868 | | | 2,049 | |
Net income attributable to noncontrolling interest | | (3) | | | (4) | |
Net income attributable to parent company's stockholders | | 865 | | | 2,045 | |
| | | | |
Earnings per share (Basic) attributable to parent company's stockholders | | 0.96 | | | 2.27 | |
Earnings per share (Diluted) attributable to parent company's stockholders | | 0.92 | | | 2.16 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| | | | | | | | | | | | | | |
| | Three months ended |
| | (Unaudited) |
In million of U.S. dollars | | June 29, 2024 | | July 1, 2023 |
| | | | |
| | | | |
Net income | | 354 | | | 1,003 | |
Other comprehensive income (loss), net of tax | | | | |
| | | | |
Derivative instruments: | | | | |
Change in fair value of cash-flow hedge | | (19) | | | (16) | |
Reclassification for net (gains)/losses realized and included in net income | | 5 | | | (10) | |
Total change in unrealized gains/losses on cash-flow hedge | | (14) | | | (26) | |
| | | | |
Available-for-sale debt securities: | | | | |
Change in fair value of available-for-sale debt securities | | — | | | (14) | |
Reclassification for net (gains)/losses realized and included in net income | | — | | | — | |
Total change in unrealized gains/losses on available-for sale debt securities | | — | | | (14) | |
| | | | |
Defined benefit plans: | | | | |
Actuarial gains/(losses) arising during the period | | — | | | — | |
Amortization of actuarial (gains)/losses included in net income | | 2 | | | 2 | |
Total change in unrealized gains/losses on defined benefit plans | | 2 | | | 2 | |
| | | | |
Change in foreign currency translation | | (35) | | | (3) | |
| | | | |
Other comprehensive income (loss), net of tax | | (47) | | | (41) | |
Total comprehensive income | | 307 | | | 962 | |
Less: comprehensive income (loss) attributable to noncontrolling interest | | 1 | | | 2 | |
Total comprehensive income attributable to parent company's stockholders | | 306 | | | 960 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| | | | | | | | | | | | | | |
| | Six months ended |
| | (Unaudited) |
In million of U.S. dollars | | June 29, 2024 | | July 1, 2023 |
| | | | |
| | | | |
Net income | | 868 | | | 2,049 | |
Other comprehensive income (loss), net of tax | | | | |
| | | | |
Derivative instruments: | | | | |
Change in fair value of cash-flow hedge | | (57) | | | 11 | |
Reclassification for net (gains)/losses realized and included in net income | | (5) | | | (27) | |
Total change in unrealized gains/losses on cash-flow hedge | | (62) | | | (16) | |
| | | | |
Available-for-sale debt securities: | | | | |
Change in fair value of available-for-sale debt securities | | (7) | | | (5) | |
Reclassification for net (gains)/losses realized and included in net income | | — | | | — | |
Total change in unrealized gains/losses on available-for sale debt securities | | (7) | | | (5) | |
| | | | |
Defined benefit plans: | | | | |
Actuarial gains/(losses) arising during the period | | (3) | | | — | |
Amortization of actuarial (gains)/losses included in net income | | 4 | | | 5 | |
Total change in unrealized gains/losses on defined benefit plans | | 1 | | | 5 | |
| | | | |
Change in foreign currency translation | | (124) | | | 61 | |
| | | | |
Other comprehensive income (loss), net of tax | | (192) | | | 45 | |
Total comprehensive income | | 676 | | | 2,094 | |
Less: comprehensive income (loss) attributable to noncontrolling interest | | 3 | | | 4 | |
Total comprehensive income attributable to parent company's stockholders | | 673 | | | 2,090 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED BALANCE SHEETS
| | | | | | | | | | | | | | |
In million of U.S. dollars, except share amounts | | June 29, 2024 | | December 31, 2023 |
| | (Unaudited) | | (Audited) |
ASSETS | | | | |
Current assets: | | | | |
Cash and cash equivalents | | 3,092 | | | 3,222 | |
Short-term deposits | | 975 | | | 1,226 | |
Marketable securities | | 2,218 | | | 1,635 | |
Trade accounts receivable, net | | 1,708 | | | 1,731 | |
Inventories | | 2,810 | | | 2,698 | |
Other current assets | | 1,066 | | | 1,295 | |
Total current assets | | 11,869 | | | 11,807 | |
Goodwill | | 296 | | | 303 | |
Other intangible assets, net | | 353 | | | 367 | |
Property, plant and equipment, net | | 10,869 | | | 10,554 | |
Non-current deferred tax assets | | 575 | | | 592 | |
Long-term investments | | 20 | | | 22 | |
Other non-current assets | | 924 | | | 808 | |
| | | | |
Total assets | | 24,906 | | | 24,453 | |
| | | | |
LIABILITIES AND STOCKHOLDERS' EQUITY | | | | |
Current liabilities: | | | | |
Short-term debt | | 236 | | | 217 | |
Trade accounts payable | | 1,577 | | | 1,856 | |
Other payables and accrued liabilities | | 1,344 | | | 1,525 | |
Dividends payable to stockholders | | 257 | | | 54 | |
Accrued income tax | | 131 | | | 78 | |
Total current liabilities | | 3,545 | | | 3,730 | |
| | | | |
Long-term debt | | 2,850 | | | 2,710 | |
Post-employment benefit obligations | | 375 | | | 372 | |
Long-term deferred tax liabilities | | 37 | | | 54 | |
Other long-term liabilities | | 951 | | | 735 | |
| | | | |
Total liabilities | | 7,758 | | | 7,601 | |
| | | | |
Commitment and contingencies | | | | |
| | | | |
Stockholders' equity: | | | | |
| | | | |
Common stock (preferred stock: 540,000,000 shares authorized, not issued; common stock: Euro 1.04 par value, 1,200,000,000 shares authorized, 911,281,920 shares issued, 903,230,622 shares outstanding as of June 29, 2024) | | 1,157 | | | 1,157 | |
Additional paid-in capital | | 2,985 | | | 2,866 | |
Retained earnings | | 12,813 | | | 12,470 | |
Accumulated other comprehensive income | | 421 | | | 613 | |
Treasury stock | | (354) | | | (377) | |
Total parent company stockholders' equity | | 17,022 | | | 16,729 | |
Noncontrolling interest | | 126 | | | 123 | |
Total stockholders' equity | | 17,148 | | | 16,852 | |
| | | | |
Total liabilities and stockholders' equity | | 24,906 | | | 24,453 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF EQUITY
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
In million of U.S. dollars | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | Common Stock | | Additional Paid-In Capital | | Treasury Stock | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Non controlling Interest | | Total Equity |
Balance as of April 1, 2023 (Unaudited) | | 1,157 | | | 2,693 | | | (352) | | | 9,754 | | | 546 | | | 67 | | | 13,865 | |
Repurchase of common stock | | | | | | (86) | | | | | | | | | (86) | |
| | | | | | | | | | | | | | |
Stock-based compensation expense | | | | 50 | | | 197 | | | (197) | | | | | | | 50 | |
Comprehensive income: | | | | | | | | | | | | | | |
Net income | | | | | | | | 1,001 | | | | | 2 | | | 1,003 | |
Other comprehensive income (loss), net of tax | | | | | | | | | | (41) | | | | | (41) | |
Comprehensive income | | | | | | | | | | | | | | 962 | |
| | | | | | | | | | | | | | |
Dividends, $0.24 per share | | | | | | | | (218) | | | | | | | (218) | |
Balance as of July 1, 2023 (Unaudited) | | 1,157 | | | 2,743 | | | (241) | | | 10,340 | | | 505 | | | 69 | | | 14,573 | |
| | | | | | | | | | | | | | |
| | Common Stock | | Additional Paid-In Capital | | Treasury Stock | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Non controlling Interest | | Total Equity |
Balance as of March 30, 2024 (Unaudited) | | 1,157 | | | 2,931 | | | (463) | | | 12,982 | | | 468 | | | 124 | | | 17,199 | |
Repurchase of common stock | | | | | | (89) | | | | | | | | | (89) | |
Stock-based compensation expense | | | | 54 | | | 198 | | | (198) | | | | | 1 | | 55 | |
Comprehensive income: | | | | | | | | | | | | | | |
Net income | | | | | | | | 353 | | | | | 1 | | | 354 | |
Other comprehensive income (loss), net of tax | | | | | | | | | | (47) | | | | | (47) | |
Comprehensive income | | | | | | | | | | | | | | 307 | |
Dividends, $0.36 per share | | | | | | | | (324) | | | | | | | (324) | |
| | | | | | | | | | | | | | |
Balance as of June 29, 2024 (Unaudited) | | 1,157 | | | 2,985 | | | (354) | | | 12,813 | | | 421 | | | 126 | | | 17,148 | |
| | | | | | | | | | | | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF EQUITY
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
In million of U.S. dollars | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | Common Stock | | Additional Paid-In Capital | | Treasury Stock | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Non controlling Interest | | Total Equity |
Balance as of December 31, 2022 (Audited) | | 1,157 | | | 2,631 | | | (268) | | | 8,713 | | | 460 | | | 65 | | | 12,758 | |
Repurchase of common stock | | | | | | (173) | | | | | | | | | (173) | |
Stock-based compensation expense | | | | 112 | | | 200 | | | (200) | | | | | | | 112 | |
Comprehensive income: | | | | | | | | | | | | | | |
Net income | | | | | | | | 2,045 | | | | | 4 | | | 2,049 | |
Other comprehensive income (loss), net of tax | | | | | | | | | | 45 | | | | | 45 | |
Comprehensive income | | | | | | | | | | | | | | 2,094 | |
| | | | | | | | | | | | | | |
Dividends, $0.24 per share | | | | | | | | (218) | | | | | | | (218) | |
Balance as of July 1, 2023 (Unaudited) | | 1,157 | | | 2,743 | | | (241) | | | 10,340 | | | 505 | | | 69 | | | 14,573 | |
| | | | | | | | | | | | | | |
| | Common Stock | | Additional Paid-In Capital | | Treasury Stock | | Retained Earnings | | Accumulated Other Comprehensive Income (Loss) | | Non controlling Interest | | Total Equity |
Balance as of December 31, 2023 (Audited) | | 1,157 | | | 2,866 | | | (377) | | | 12,470 | | | 613 | | | 123 | | | 16,852 | |
Repurchase of common stock | | | | | | (175) | | | | | | | | | (175) | |
Stock-based compensation expense | | | | 119 | | | 198 | | | (198) | | | | | | | 119 | |
Comprehensive income: | | | | | | | | | | | | | | |
Net income | | | | | | | | 865 | | | | | 3 | | | 868 | |
Other comprehensive income (loss), net of tax | | | | | | | | | | (192) | | | | | (192) | |
Comprehensive income | | | | | | | | | | | | | | 676 | |
Dividends, $0.36 per share | | | | | | | | (324) | | | | | | | (324) | |
Balance as of June 29, 2024 (Unaudited) | | 1,157 | | | 2,985 | | | (354) | | | 12,813 | | | 421 | | | 126 | | | 17,148 | |
| | | | | | | | | | | | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
CONSOLIDATED STATEMENTS OF CASH FLOWS
| | | | | | | | | | | | | | |
| | Six Months ended |
| | (Unaudited) |
In million of U.S. dollars | | June 29, 2024 | | July 1, 2023 |
Cash flows from operating activities: | | | | |
Net income | | 868 | | | 2,049 | |
Items to reconcile net income and cash flows from operating activities: | | | | |
Depreciation and amortization | | 868 | | | 751 | |
Amortization of issuance costs on convertible bonds | | 1 | | | 1 | |
| | | | |
Loss on financial instruments, net | | 1 | | | — | |
Non-cash stock-based compensation | | 119 | | | 112 | |
Other non-cash items | | (107) | | | (28) | |
Deferred income tax | | 4 | | | 72 | |
| | | | |
| | | | |
Changes in assets and liabilities: | | | | |
Trade receivables, net | | 7 | | | (27) | |
Inventories | | (148) | | | (437) | |
Trade payables | | 147 | | | (79) | |
Other assets and liabilities, net | | (199) | | | 217 | |
Net cash from operating activities | | 1,561 | | | 2,631 | |
| | | | |
Cash flows used in investing activities: | | | | |
Payment for purchase of tangible assets | | (1,835) | | | (2,204) | |
Proceeds from capital grants and other contributions | | 292 | | | 37 | |
Proceeds from sale of tangible assets | | 3 | | | 6 | |
Payment for purchase of marketable securities | | (1,301) | | | (660) | |
Proceeds from matured marketable securities | | 750 | | | — | |
Net proceeds from (investment in) short-term deposits | | 250 | | | 475 | |
Payment for purchase of intangible assets | | (41) | | | (46) | |
Payment for purchase of financial assets | | — | | | (8) | |
| | | | |
| | | | |
| | | | |
Net cash used in investing activities | | (1,882) | | | (2,400) | |
| | | | |
Cash flows from (used in) financing activities: | | | | |
Proceeds from long-term debt | | 300 | | | — | |
| | | | |
| | | | |
Repayment of long-term debt | | (95) | | | (93) | |
| | | | |
Repurchase of common stock | | (175) | | | (173) | |
Dividends paid to stockholders | | (121) | | | (105) | |
| | | | |
Payment for withholding tax on vested shares | | (5) | | | (7) | |
| | | | |
Proceeds from advances on capital grants | | 295 | | | — | |
Other financing activities | | (3) | | | (2) | |
Net cash from (used in) financing activities | | 196 | | | (380) | |
Effect of changes in exchange rates | | (5) | | | 2 | |
Net cash decrease | | (130) | | | (147) | |
Cash and cash equivalents at beginning of the period | | 3,222 | | | 3,258 | |
Cash and cash equivalents at end of the period | | 3,092 | | | 3,111 | |
| | | | |
The accompanying notes are an integral part of these unaudited consolidated financial statements |
STMicroelectronics N.V.
Notes to Interim Consolidated Financial Statements (Unaudited)
1.The Company
STMicroelectronics N.V. (the “Company”) is registered in the Netherlands with its corporate legal seat in Amsterdam, the Netherlands, and its corporate headquarters located in Geneva, Switzerland.
The Company is a global semiconductor company that designs, develops, manufactures and markets a broad range of products, including discrete and general-purpose components, application-specific integrated circuits (“ASICs”), full custom devices and semi-custom devices and application-specific standard products (“ASSPs”) for analog, digital and mixed-signal applications. In addition, the Company participates in the manufacturing value chain of smartcard products, which includes the production and sale of both silicon chips and smartcards.
2.Fiscal Year
The Company’s fiscal year ends on December 31. Interim periods are established for accounting purposes on a thirteen-week basis.
The Company’s first quarter ended on March 30, the second quarter ended on June 29, its third quarter will end on September 28, and its fourth quarter will end on December 31.
3.Basis of Presentation
The accompanying unaudited interim consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), consistent in all material respects with those applied for the year ended December 31, 2023. The interim financial information is unaudited but reflects all normal adjustments which are, in the opinion of management, necessary to provide a fair statement of results for the periods presented. The results of operations for the interim period are not necessarily indicative of the results to be expected for the entire year.
All balances and values in the current and prior periods are in millions of U.S. dollars, except share and per-share amounts.
The accompanying unaudited interim consolidated financial statements do not include certain footnotes and financial disclosures normally required on an annual basis under U.S. GAAP. Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, as filed with the U.S. Securities and Exchange Commission (the “SEC”) on February 22, 2024.
4.Use of Estimates
The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions. The primary areas that require significant estimates and judgments by management include, but are not limited to:
•sales allowances for discounts, price protection, product returns and other rebates,
•inventory obsolescence reserves and assessment of normal manufacturing capacity to determine costs capitalized in inventory,
•recognition and measurement of loss contingencies,
•valuation at fair value of assets acquired and liabilities assumed on business acquisitions, and measurement of any contingent consideration,
•annual and trigger-based impairment review of goodwill and intangible assets, as well as the assessment of events which could trigger impairment testing on tangible assets,
•assessment of the Company’s long-lived assets economic useful lives,
•assumptions used in measuring expected credit losses and impairment charges on financial assets,
•assumptions used in assessing the number of awards expected to vest on stock-based compensation plans,
•assumptions used in calculating net defined pension benefit obligations and other long-term employee benefits,
•determination of the amount of tax expected to be paid and tax benefit expected to be received, including deferred income tax assets, valuation allowance and provisions for uncertain tax positions and claims.
The Company bases the estimates and assumptions on historical experience and on various other factors such as market trends, market information used by market participants and the latest available business plans that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. While the Company regularly evaluates its estimates and assumptions, the actual results experienced by the Company could differ materially and adversely from those estimates.
5.Recent Accounting Pronouncements
The Company did not adopt in the first six months of 2024 any new accounting guidance that would have a material impact on its financial position and results of operations.
In November 2023, the FASB issued new guidance related to segment reporting, which requires incremental disclosures about reportable segments, without changing though the definition of a segment or the guidance for determining reportable segments. The new guidance requires disclosures of significant segment expenses that are (i) regularly provided to (or easily computed from information regularly provided to) the chief operating decision maker (“CODM”); (ii) included in the reported measure of segment profit or loss. Moreover, annual disclosures about a reportable segment's profit or loss and assets become mandatory on interim periods. Finally, the title and position of the CODM, together with an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources, are also required. The guidance is effective for the Company's 2024 annual reporting and 2025 interim periods onwards. The guidance will be applied retrospectively. The Company will adopt the new guidance when effective and is currently assessing the impact the new guidance will have on its segment reporting.
In December 2023, the FASB issued new guidance related to income taxes, which requires additional disclosures, primarily around disaggregation of income tax paid and specific categories in the income tax rate reconciliation. The guidance is effective for the year ended December 31, 2025, with early adoption permitted. The guidance will be applied prospectively. Retrospective application is permitted. The Company will adopt the new guidance when effective and will amend its annual disclosures accordingly.
6.Other Income and Expenses, Net
Other income and expenses, net consisted of the following:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months ended | | Six Months ended |
| | June 29, 2024 | | July 1, 2023 | | June 29, 2024 | | July 1, 2023 |
Public funding | | 58 | | 27 | | 151 | | 52 |
Start-up costs | | (22) | | (34) | | (52) | | (67) |
Exchange gains (losses), net | | (1) | | 3 | | (2) | | 3 |
Patent costs | | (1) | | (2) | | (4) | | (5) |
Gain on sale of non-current assets | | 1 | | 4 | | 3 | | 5 |
| | | | | | | | |
Other, net | | (2) | | (2) | | (3) | | (2) |
Total | | 33 | | (4) | | 93 | | (14) |
The Company receives public funding from governmental bodies in several countries.
Start-up costs represent costs incurred in the ramp-up phase of the Company’s newly integrated manufacturing facilities.
Exchange gains and losses, net represent the portion of exchange rate changes on transactions denominated in currencies other than a subsidiary’s functional currency and the changes in fair value of derivative instruments which are not designated as hedges, as described in Note 28.
Patent costs mainly include legal and attorney fees and payment for claims, patent pre-litigation consultancy and legal fees. They are reported net of settlements, if any, which primarily include reimbursements of prior patent litigation costs.